Le Lézard
Classified in: Health, Science and technology
Subject: PERSONNEL ANNOUNCEMENTS

Mike Imagawa named Managing Director, SE Asia of The Coretec Group, Inc.


TULSA, OK--(Marketwired - August 10, 2017) - The Coretec Group, Inc. (OTC PINK: CRTG) announced today that Mike Imagawa has been appointed to the position of Managing Director, Southeast Asia. In this role, Mr. Imagawa will focus on business development for energy storage and semiconductor markets in both Japan and Korea.

"I am very pleased to add Mike to the Coretec team," said Michael Kraft, The Coretec Group CEO. "The creation of this significant role was necessitated by the fact that we have been exploring, in part with Mike's valuable assistance, the development of one or more strategic partnerships in this geographical area. His experience with the energy storage and semiconductor markets is a perfect fit to advance our Coretec® HexaSilanetm technology and these relationships."

Mr. Imagawa has a demonstrated understanding of customer requirements coupled with extensive business development experience in important target markets. Prior to joining The Coretec Group, he enjoyed a distinguished career that included business development positions at GE, Umicore and Dow Corning. Mr. Imagawa holds a bachelor's degree from Kansai Gaidai University. He will remain located in Tokyo, Japan.

About The Coretec Group, Inc.
The Coretec Group, Inc. (the "Company") utilizes a portfolio of silicon-based materials to pursue commercial development in energy-focused verticals such as energy storage, solar, and solid-state lighting, as well as printable electronics and 3D displays.

For more information, visit www.thecoretecgroup.com.


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: